Novartis to Acquire Regulus in $1.7 Billion Deal
wsj.com/business/deals/novartis-to-acquire-regulus-in-1-7-billion-deal-6701a037With the merger, the Swiss pharmaceutical company aims to bring to more patients farabursen, a kidney-disease treatment developed by Regulus.
This story appeared on wsj.com, 2025-04-30 11:50:00.